Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01960322 · ClinicalTrials.gov registry record · Phase 1
Improving Medication-taking After Liver Transplant
A Phase 1 study of Nonadherence and Tacrolimus, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
- 3
- Study locations
NCT01960322 is a Phase 1 study of Nonadherence and Tacrolimus that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 7 participants. The trial reports 3 study locations across 3 states.
The verdict
NCT01960322, a Phase 1 study of Nonadherence and Tacrolimus, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
- 3
- Study locations
Study Summary
The specific aim is to pilot-test our developed intervention manual's ability to improve patients' adherence to medications and medical outcomes (rejection rate, liver enzyme levels) in participating centers.
Conditions Studied
Interventions
- BEHAVIORAL Telemetric
Study Locations (3)
California
- UCLA Mattell Children's Hospital - Los Angeles
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Pennsylvania
- Children's Hospital of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-08 |
| Est. Completion | 2016-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01960322
The ClinicalTrials.gov registry entry for NCT01960322 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Nonadherence appearing as the primary indexed condition, and to 1 intervention - of which Telemetric is the first listed.
NCT01960322 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01960322 about?
NCT01960322 is a clinical study titled "Improving Medication-taking After Liver Transplant". The specific aim is to pilot-test our developed intervention manual's ability to improve patients' adherence to medications and medical outcomes (rejection rate, liver enzyme levels) in participating centers.
What is the current status of trial NCT01960322?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2014-08. Estimated completion is 2016-05.
What conditions does trial NCT01960322 study?
This clinical trial studies the following conditions: Nonadherence, Tacrolimus, Pediatric Liver Transplant Recipients.
What interventions are being tested in trial NCT01960322?
The interventions under investigation include: Telemetric (BEHAVIORAL).
Who is sponsoring clinical trial NCT01960322?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01960322 being conducted?
This trial has 3 study locations across California, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.